{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:56:51Z","timestamp":1794023811827,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Trends in prescribing psychotropic drugs before and during pregnancy may have changed over the years, but actual information is lacking. We therefore compared and assessed the exposure and acceptance rates of classes of antipsychotic (+ lithium), anxiolytic, sedative\/hypnotic, antidepressant, and psychostimulant before and during pregnancy in the past two decades. All singleton pregnancies with \u22651 prescription of psychotropic drug from six months before pregnancy until child\u2019s birthdate were identified in the pregnancy subset of the IADB.nl prescription database. The prescription patterns of psychotropics were distinguished as continuation rate (CR), initiation rate (IR), discontinuation rate (DR), total exposure rate (TER), and acceptance rate. Singleton pregnancies exposed to psychotropic drugs before and during pregnancy increased from 118.4 to 136.5 (per 1000 singleton pregnancies) between decades. Changing trends were observed in decade 2, including a high increase in the TER of antipsychotic class (3.3 to 6.8) and antidepressant class (23.0 to 40.6). A marked increase for individual drugs was seen for sertraline (TER: 0.6 to 6.6 and PAT: 35.3% to 82.5%), citalopram (TER: 2.3 to 10.0 and PAT: 51.1% to 74.6%), and quetiapine (TER: 0.4 to 3.1 and PAT: 57.1% to 66.0%). Although the total exposure rates of five classes of psychotropics in singleton pregnancies increased in decade 2, only antidepressant class had a higher acceptance rate during pregnancy. Certain SSRI antidepressants and atypical antipsychotics were more frequently prescribed in decade 2 than in decade 1, reflecting that treatment options were preferred for safer treatment choices.<\/jats:p>","DOI":"10.1007\/s00737-023-01290-8","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T03:02:28Z","timestamp":1673665348000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Exposure to psychotropic drugs before and during pregnancy: what has changed over the last two decades?"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5522-6785","authenticated-orcid":false,"given":"Robiyanto","family":"Robiyanto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8527-2608","authenticated-orcid":false,"given":"Catharina C M","family":"Schuiling-Veninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9209-7564","authenticated-orcid":false,"given":"Jens H J","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0849-7210","authenticated-orcid":false,"given":"Eelko","family":"Hak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2236-1398","authenticated-orcid":false,"given":"Eug\u00e8ne P","family":"van Puijenbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,14]]},"reference":[{"key":"1290_CR1","doi-asserted-by":"publisher","first-page":"21f14265","DOI":"10.4088\/JCP.21f14265","volume":"82","author":"C Andrade","year":"2021","unstructured":"Andrade C (2021) Gestational and neurodevelopmental outcomes associated with antipsychotic drug exposure during pregnancy. J Clin Psychiatry 82:21f14265. https:\/\/doi.org\/10.4088\/JCP.21f14265","journal-title":"J Clin Psychiatry"},{"key":"1290_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1471-0528.2006.00927.x","volume":"113","author":"MK Bakker","year":"2006","unstructured":"Bakker MK, Jentink J, Vroom F et al (2006) Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG 113:559\u2013568. https:\/\/doi.org\/10.1111\/j.1471-0528.2006.00927.x","journal-title":"BJOG"},{"key":"1290_CR3","doi-asserted-by":"publisher","unstructured":"Bellantuono C, Martellini M, Orsolini L (2019) Benzodiazepines and Z-drugs in pregnancy. Perinatal Psychopharmacology 203\u2013213. https:\/\/doi.org\/10.1007\/978-3-319-92919-4_11\/COVER","DOI":"10.1007\/978-3-319-92919-4_11\/COVER"},{"key":"1290_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2125.2007.03048.x","volume":"65","author":"MK Bakker","year":"2008","unstructured":"Bakker MK, K\u00f6lling P, van den Berg PB et al (2008) Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol 65:600\u2013606. https:\/\/doi.org\/10.1111\/j.1365-2125.2007.03048.x","journal-title":"Br J Clin Pharmacol"},{"key":"1290_CR5","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/bcp.13608","volume":"84","author":"A B\u00e9nard-Laribi\u00e8re","year":"2018","unstructured":"B\u00e9nard-Laribi\u00e8re A, Pambrun E, Sutter-Dallay A-L et al (2018) Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study. Br J Clin Pharmacol 84:1764\u20131775. https:\/\/doi.org\/10.1111\/bcp.13608","journal-title":"Br J Clin Pharmacol"},{"key":"1290_CR6","unstructured":"Bijwerkingen Centrum Lareb (2020) Amphetamines in ADHD during pregnancy. https:\/\/www.lareb.nl\/mvm-kennis-pagina?id = 19&pagina = 1&zoekterm = N06BA04&zwangerschap = true&borstvoeding = false&naam = Amfetaminen%20bij%20ADHD%20tijdens%20de%20zwangerschap. Accessed 5 Oct 2020"},{"key":"1290_CR7","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1111\/BCP.13732","volume":"84","author":"P Damkier","year":"2018","unstructured":"Damkier P, Christensen LS, Broe A (2018) Patterns and predictors for prescription of psychotropics and mood-stabilizing antiepileptics during pregnancy in Denmark 2000\u20132016. Br J Clin Pharmacol 84:2651\u20132662. https:\/\/doi.org\/10.1111\/BCP.13732","journal-title":"Br J Clin Pharmacol"},{"key":"1290_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/ajo.13352","volume":"61","author":"S Donald","year":"2021","unstructured":"Donald S, Sharples K, Barson D et al (2021) Antidepressant dispensing before, during, and after pregnancy in New Zealand, 2005-2014. Aust N Z J Obstet Gynaecol 61:837\u2013845. https:\/\/doi.org\/10.1111\/ajo.13352","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"1290_CR9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Nix CA, Hollier J et al (2021) Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int 13:594\u2013607. https:\/\/doi.org\/10.3390\/neurolint13040059","journal-title":"Neurol Int"},{"key":"1290_CR10","unstructured":"Farmacotherapeutisch Kompas (2020) Methylphenidate in pregnancy. https:\/\/www.farmacotherapeutischkompas.nl\/bladeren\/preparaatteksten\/m\/methylfenidaat#zwangerschap. Accessed 5 Oct 2020"},{"key":"1290_CR11","unstructured":"Federatie Medisch Specialisten (2020a) Antipsychotics and non-SSRI antidepressants during pregnancy and lactation - NVOG - Richtlijnendatabase. https:\/\/richtlijnendatabase.nl\/richtlijn\/antipsychotica_en_niet-ssri_antidepressiva_tijdens_zwangerschap_en_lactatie\/startpagina_-_antipsychotica_en_niet-ssri_antidepressiva_tijdens_zwangerschap_en_lactatie.html. Accessed 5 Oct 2020"},{"key":"1290_CR12","unstructured":"Federatie Medisch Specialisten (2020b) Benzodiazepine use in pregnancy- NVOG - Richtlijnendatabase. https:\/\/richtlijnendatabase.nl\/richtlijn\/benzodiazepinegebruik_in_de_zwangerschap\/benzodiazepinengebruik_-_startpagina.html. Accessed 5 Oct 2020"},{"key":"1290_CR13","unstructured":"Federatie Medisch Specialisten (2020c) SSRI and pregnancy - NVOG - Richtlijnenatabase. https:\/\/richtlijnendatabase.nl\/richtlijn\/ssri_en_zwangerschap\/ssri-gebruik_en_zwangerschap_-_startpagina.html. Accessed 5 Oct 2020"},{"key":"1290_CR14","unstructured":"Federatie Medisch Specialisten (2020d) Recommendations ADHD in adults - NVvP - Richtlijnenatabase. https:\/\/richtlijnendatabase.nl\/richtlijn\/adhd_bij_volwassenen\/medicamenteuze_behandeling_adhd\/aanbevelingen_adhd_bij_volwassenen.html. Accessed 5 Oct 2020"},{"key":"1290_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/1471-2393-14-242","volume":"14","author":"GE Hanley","year":"2014","unstructured":"Hanley GE, Mintzes B (2014) Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy Childbirth 14:242. https:\/\/doi.org\/10.1186\/1471-2393-14-242","journal-title":"BMC Pregnancy Childbirth"},{"key":"1290_CR16","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.3389\/FPHAR.2022.1000018\/BIBTEX","volume":"13","author":"CAM Hartwig","year":"2022","unstructured":"Hartwig CAM, Robiyanto R, de Vos S et al (2022) In utero antidepressant exposure not associated with ADHD in the offspring: a case control sibling design. Front Pharmacol 13:4797. https:\/\/doi.org\/10.3389\/FPHAR.2022.1000018\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"1290_CR17","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1111\/bcp.14341","volume":"86","author":"E Houben","year":"2020","unstructured":"Houben E, te Winkel B, Steegers EAP, Herings RMC (2020) Dutch trends in the use of potentially harmful medication during pregnancy. Br J Clin Pharmacol 86:2377\u20132392. https:\/\/doi.org\/10.1111\/bcp.14341","journal-title":"Br J Clin Pharmacol"},{"key":"1290_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0092778","volume":"9","author":"KF Huybrechts","year":"2014","unstructured":"Huybrechts KF, Sanghani RS, Avorn J, Urato AC (2014) Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLoS One 9:e92778. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0092778","journal-title":"PLoS One"},{"key":"1290_CR19","unstructured":"IADB.nl (2020) IADB.nl Drug use research. https:\/\/iadb.nl\/. Accessed 1 Sep 2020"},{"key":"1290_CR20","doi-asserted-by":"publisher","first-page":"e003507","DOI":"10.1136\/BMJOPEN-2013-003507","volume":"3","author":"K Laugesen","year":"2013","unstructured":"Laugesen K, Olsen MS, Andersen ABT et al (2013) In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study. BMJ Open 3:e003507. https:\/\/doi.org\/10.1136\/BMJOPEN-2013-003507","journal-title":"BMJ Open"},{"key":"1290_CR21","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1111\/1471-0528.16743","volume":"128","author":"A Lupattelli","year":"2021","unstructured":"Lupattelli A, Mahic M, Handal M et al (2021) Attention-deficit\/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study. BJOG 128:1917\u20131927. https:\/\/doi.org\/10.1111\/1471-0528.16743","journal-title":"BJOG"},{"key":"1290_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/S00737-019-0951-5\/TABLES\/4","volume":"23","author":"NM Molenaar","year":"2020","unstructured":"Molenaar NM, den Berg MPL, Bonsel GJ (2020) Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands. Arch Womens Ment Health 23:71\u201379. https:\/\/doi.org\/10.1007\/S00737-019-0951-5\/TABLES\/4","journal-title":"Arch Womens Ment Health"},{"key":"1290_CR23","doi-asserted-by":"publisher","unstructured":"Orsolini L, Bellantuono C (2022) Psychotropic drugs in pregnancy and breastfeeding. Key Topics in Perinatal Mental Health 245\u2013269. https:\/\/doi.org\/10.1007\/978-3-030-91832-3_16","DOI":"10.1007\/978-3-030-91832-3_16"},{"key":"1290_CR24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMc1708919","volume":"377","author":"E Patorno","year":"2017","unstructured":"Patorno E, Huybrechts KF, Hernandez-Diaz S (2017) Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 377:893\u2013894. https:\/\/doi.org\/10.1056\/NEJMc1708919","journal-title":"N Engl J Med"},{"key":"1290_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/BMJ.B3569","volume":"339","author":"LH Pedersen","year":"2009","unstructured":"Pedersen LH, Henriksen TB, Vestergaard M et al (2009) Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 339:735. https:\/\/doi.org\/10.1136\/BMJ.B3569","journal-title":"BMJ"},{"key":"1290_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2002.12.001","volume":"57","author":"E Schirm","year":"2004","unstructured":"Schirm E, Tobi H (2004) Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J Clin Epidemiol 57:737\u2013741. https:\/\/doi.org\/10.1016\/j.jclinepi.2002.12.001","journal-title":"J Clin Epidemiol"},{"key":"1290_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejogrb.2003.10.024","volume":"114","author":"E Schirm","year":"2004","unstructured":"Schirm E, Meijer WM, Tobi H (2004) Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system. Eur J Obstet Gynecol Reprod Biol 114:182\u2013188. https:\/\/doi.org\/10.1016\/j.ejogrb.2003.10.024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1290_CR28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/CLEP.S163037","volume":"10","author":"R Sediq","year":"2018","unstructured":"Sediq R, van der Schans J, Dotinga A et al (2018) Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative. Clin Epidemiol 10:981\u2013989. https:\/\/doi.org\/10.2147\/CLEP.S163037","journal-title":"Clin Epidemiol"},{"key":"1290_CR29","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/JAMAINTERNMED.2022.0375","volume":"182","author":"L Straub","year":"2022","unstructured":"Straub L, Hern\u00e1ndez-D\u00edaz S, Bateman BT et al (2022) Association of antipsychotic drug exposure in pregnancy with risk of neurodevelopmental disorders: a national birth cohort study. JAMA Intern Med 182:522\u2013533. https:\/\/doi.org\/10.1001\/JAMAINTERNMED.2022.0375","journal-title":"JAMA Intern Med"},{"key":"1290_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1586\/erp.13.20","volume":"13","author":"ST Visser","year":"2013","unstructured":"Visser ST, Schuiling-Veninga CCM, Bos JHJ et al (2013) The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges. Expert Rev Pharmacoecon Outcomes Res 13:285\u2013292. https:\/\/doi.org\/10.1586\/erp.13.20","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"1290_CR31","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamainternmed.2021.4571","volume":"181","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chan AYL, Coghill D et al (2021) Association between prenatal exposure to antipsychotics and attention-deficit\/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age. JAMA Intern Med 181:1332\u20131340. https:\/\/doi.org\/10.1001\/jamainternmed.2021.4571","journal-title":"JAMA Intern Med"},{"key":"1290_CR32","unstructured":"WHOCC (2020) ATC\/DDD Index - WHO Collaborating Centre for Drug Statistics Methodology. https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 5 Oct 2020"},{"key":"1290_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/J.REPROTOX.2012.04.015","volume":"34","author":"G W\u2019t Jong","year":"2012","unstructured":"W\u2019t Jong G, Einarson T, Koren G, Einarson A (2012) Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): a systematic review. Reprod Toxicol 34:293\u2013297. https:\/\/doi.org\/10.1016\/J.REPROTOX.2012.04.015","journal-title":"Reprod Toxicol"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-023-01290-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00737-023-01290-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-023-01290-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T05:13:19Z","timestamp":1675833199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00737-023-01290-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,14]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1290"],"URL":"https:\/\/doi.org\/10.1007\/s00737-023-01290-8","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,14]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Under Dutch law, subject consent or approval from an Ethics Committee is not required for anonymized healthcare data for pharmacoepidemiological research. The database complies with the European data protection law.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}